Oscar Health Cut to Underperform From Neutral by B of A Securities
Oscar Health Analyst Ratings
BofA Securities Downgrades Oscar Health(OSCR.US) to Sell Rating, Cuts Target Price to $13.5
UBS Initiates Oscar Health With Neutral Rating, $23 Price Target
Oscar Health Analyst Ratings
Piper Sandler Maintains Oscar Health(OSCR.US) With Buy Rating, Maintains Target Price $28
Oscar Health (OSCR) Receives a Buy From Piper Sandler
Oscar Health Price Target Raised to $28.00/Share From $25.00 by Piper Sandler
Oscar Health Analyst Ratings
Buy Rating Affirmed: Oscar Health's Strong Financials Signal Continued Growth
Oscar Health Analyst Ratings
Piper Sandler Maintains Overweight on Oscar Health, Maintains $25 Price Target
Oscar Health Analyst Ratings
Oscar Health Analyst Ratings
Wells Fargo Maintains Overweight on Oscar Health, Raises Price Target to $27
B of A Securities Downgrades Oscar Health to Neutral, Lowers Price Target to $21
Oscar Health Analyst Ratings
Baird Initiates Coverage On Oscar Health With Outperform Rating, Announces Price Target of $28
Oscar Health Analyst Ratings
B of A Securities Maintains Buy on Oscar Health, Raises Price Target to $25